Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Editing | 7 | 2023 | 318 | 2.110 |
Why?
|
| CRISPR-Cas Systems | 6 | 2023 | 358 | 1.900 |
Why?
|
| Proteins | 3 | 2025 | 750 | 1.780 |
Why?
|
| Peptides | 2 | 2025 | 574 | 1.350 |
Why?
|
| Induced Pluripotent Stem Cells | 4 | 2025 | 147 | 1.350 |
Why?
|
| Computational Biology | 2 | 2025 | 356 | 1.300 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2021 | 99 | 1.270 |
Why?
|
| Streptococcus | 3 | 2020 | 17 | 0.940 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 58 | 0.890 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2025 | 263 | 0.820 |
Why?
|
| Software | 1 | 2025 | 388 | 0.730 |
Why?
|
| Amino Acid Sequence | 5 | 2024 | 1592 | 0.720 |
Why?
|
| Cell Differentiation | 3 | 2025 | 1347 | 0.690 |
Why?
|
| Dinucleoside Phosphates | 1 | 2020 | 32 | 0.660 |
Why?
|
| Nucleotide Motifs | 1 | 2020 | 52 | 0.650 |
Why?
|
| Adenine | 1 | 2020 | 50 | 0.650 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 152 | 0.640 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 113 | 0.640 |
Why?
|
| Transcription Factors | 2 | 2025 | 1512 | 0.640 |
Why?
|
| In Vitro Oocyte Maturation Techniques | 2 | 2024 | 8 | 0.440 |
Why?
|
| HEK293 Cells | 3 | 2020 | 619 | 0.410 |
Why?
|
| Germ Cells | 2 | 2025 | 110 | 0.390 |
Why?
|
| Protein Engineering | 2 | 2025 | 82 | 0.390 |
Why?
|
| Proteolysis | 2 | 2025 | 145 | 0.370 |
Why?
|
| Genome | 2 | 2023 | 276 | 0.350 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2023 | 220 | 0.330 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2021 | 489 | 0.310 |
Why?
|
| Humans | 13 | 2025 | 63309 | 0.280 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 1650 | 0.250 |
Why?
|
| Oocytes | 2 | 2024 | 198 | 0.240 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2025 | 5 | 0.240 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2025 | 17 | 0.230 |
Why?
|
| Protein Stability | 1 | 2025 | 92 | 0.230 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2025 | 125 | 0.220 |
Why?
|
| Ovulation Induction | 1 | 2024 | 13 | 0.220 |
Why?
|
| Catalytic Domain | 1 | 2025 | 199 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 197 | 0.210 |
Why?
|
| Proteomics | 1 | 2025 | 283 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2025 | 304 | 0.200 |
Why?
|
| Cell Cycle Proteins | 1 | 2025 | 393 | 0.190 |
Why?
|
| Protein Conformation | 1 | 2024 | 779 | 0.180 |
Why?
|
| Cytosine | 1 | 2021 | 31 | 0.180 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 382 | 0.170 |
Why?
|
| Virus Attachment | 1 | 2020 | 18 | 0.170 |
Why?
|
| Transcriptome | 1 | 2024 | 388 | 0.170 |
Why?
|
| Receptors, Virus | 1 | 2020 | 73 | 0.170 |
Why?
|
| DNA Cleavage | 1 | 2020 | 19 | 0.170 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2020 | 126 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 1 | 2021 | 517 | 0.160 |
Why?
|
| Protein Domains | 1 | 2020 | 147 | 0.160 |
Why?
|
| Apoptosis | 1 | 2025 | 1074 | 0.160 |
Why?
|
| Ribonucleoproteins | 1 | 2020 | 114 | 0.160 |
Why?
|
| Nanoparticles | 1 | 2025 | 513 | 0.150 |
Why?
|
| Sequence Homology | 1 | 2018 | 20 | 0.150 |
Why?
|
| Binding Sites | 1 | 2020 | 903 | 0.140 |
Why?
|
| Substrate Specificity | 1 | 2018 | 335 | 0.140 |
Why?
|
| Genetic Engineering | 1 | 2018 | 116 | 0.140 |
Why?
|
| Genome, Human | 1 | 2018 | 237 | 0.130 |
Why?
|
| Mutation | 1 | 2025 | 2607 | 0.130 |
Why?
|
| Protein Binding | 1 | 2020 | 1602 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 672 | 0.120 |
Why?
|
| Glycolysis | 1 | 2015 | 57 | 0.110 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2015 | 59 | 0.110 |
Why?
|
| Lipolysis | 1 | 2015 | 46 | 0.110 |
Why?
|
| Neoplasms | 1 | 2025 | 1361 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 325 | 0.110 |
Why?
|
| Coculture Techniques | 2 | 2024 | 96 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2024 | 85 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2015 | 200 | 0.110 |
Why?
|
| Ovary | 2 | 2024 | 100 | 0.100 |
Why?
|
| Gene Library | 2 | 2021 | 102 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 641 | 0.090 |
Why?
|
| Mammals | 2 | 2023 | 217 | 0.090 |
Why?
|
| Cumulus Cells | 1 | 2024 | 6 | 0.060 |
Why?
|
| Chorionic Gonadotropin | 1 | 2024 | 15 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2022 | 2151 | 0.050 |
Why?
|
| Gonadotropins | 1 | 2023 | 14 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2024 | 85 | 0.050 |
Why?
|
| Semen | 1 | 2023 | 48 | 0.050 |
Why?
|
| Oogenesis | 1 | 2023 | 44 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 86 | 0.050 |
Why?
|
| Feeder Cells | 1 | 2022 | 1 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2021 | 165 | 0.040 |
Why?
|
| Female | 4 | 2024 | 32806 | 0.040 |
Why?
|
| Plasmids | 1 | 2021 | 291 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2021 | 134 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1007 | 0.040 |
Why?
|
| Cell Line | 1 | 2023 | 2036 | 0.040 |
Why?
|
| DNA | 1 | 2023 | 832 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2021 | 700 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 16794 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 3285 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2015 | 5 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2015 | 57 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 488 | 0.030 |
Why?
|
| Animals | 2 | 2023 | 20613 | 0.030 |
Why?
|
| Young Adult | 1 | 2023 | 4687 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 219 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 760 | 0.020 |
Why?
|
| Male | 2 | 2023 | 29834 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 10816 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 17558 | 0.020 |
Why?
|